| 中文名 | RP-3500 |
|---|---|
| 英文名 | ATR inhibitor 4 |
| 中文别名 |
(3-ENDO)-3-(6-((R)-3-甲基吗啉)-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基)-8-氧杂双环[3.2.1]辛烷-3-醇
(3-内)-3-[6-[(3R)-3-甲基-4-吗啉基]-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基]-8-氧杂双环[3.2.1]辛-3-醇 |
| 英文别名 |
camonsertib
8-Oxabicyclo[3.2.1]octan-3-ol, 3-[6-[(3R)-3-methyl-4-morpholinyl]-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]-, (3-endo) RP-3500 (Synonyms: ATR inhibitor 4) RP-3500 Camonsertib (RP-3500) (1R,5S)-3-{6-[(3R)-3-methylmorpholin-4-yl]-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl}-8-oxabicyclo[3.2.1]octan-3-ol Camonsertib, 10 mM in DMSO (3-endo)-3-(6-((R)-3-Methylmorpholino)-1-(1H-pyrazol-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)-8-oxabicyclo[3.2.1]octan-3-ol |
| 描述 | ATR抑制剂4(化合物121)是一种有效的ATR抑制剂。ATR抑制剂4具有抗肿瘤活性[1]。 |
|---|---|
| 相关类别 | |
| 靶点 |
ATR |
| 参考文献 |
[1]. Maria Koehler, et al. Use of atr inhibitors in combination with parp inhibitors. WO2021119523A1 |
| 分子式 | C21H26N6O3 |
|---|---|
| 分子量 | 410.47 |
| 储存条件 | 2-8°C |